Cargando…
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
Drug resistance continues to be a major barrier to the delivery of curative therapies in cancer. Historically, drug resistance has been associated with over-expression of drug transporters, changes in drug kinetics or amplification of drug targets. However, the emergence of resistance in patients tr...
Autores principales: | Saunders, Nicholas A, Simpson, Fiona, Thompson, Erik W, Hill, Michelle M, Endo-Munoz, Liliana, Leggatt, Graham, Minchin, Rodney F, Guminski, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494067/ https://www.ncbi.nlm.nih.gov/pubmed/22733553 http://dx.doi.org/10.1002/emmm.201101131 |
Ejemplares similares
-
Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019) -
Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
por: van Esterik, Manouk, et al.
Publicado: (2017) -
Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
por: Sharifi‐Salamatian, Vénus, et al.
Publicado: (2000) -
popFBA: tackling intratumour heterogeneity with Flux Balance Analysis
por: Damiani, Chiara, et al.
Publicado: (2017) -
Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism
por: Alfardus, Huda, et al.
Publicado: (2021)